Comprehensive cardiac resynchronization therapy optimization in the real world

Cardiology Journal

Volumn 21, Issue 3, 2014, Pages 316-324

  Steffel, Jan ^a   Rempel, Helene ^a   Breitenstein, Alexander ^a   Schmidt, Susann ^a   Namdar, Mehdi ^b   Krasniqi, Nazmi ^a   Holzmeister, Johannes ^a   Lüscher, Thomas F ^a   Ruschitzka, Frank ^a   Hürlimann, David ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UZB   (Belgium)

Author keywords

Cardiac resynchronization therapy; Heart failure; Integrative device follow up

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INTERVENTRICULAR DELAY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SUBOPTIMAL ATRIOVENTRICULAR DELAY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART RATE; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STANDARDS; TREATMENT OUTCOME;

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84902204696     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/cj.a2013.0123     Document Type: Article

References (33)

1. Hunt SA, Abraham WT, Chin MH et al. 2009 focused update incorporated into the acc/aha 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the american college of cardiology foundation/american heart association task force on practice guidelines: Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2009; 119: e391-e479.
2. Bristow MR, Saxon LA, Boehmer J et al. Defibrillation in heart failure. I. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004; 350: 2140-2150.
3. Chung ES, Leon AR, Tavazzi L et al. Results of the predictors of response to crt (prospect) trial. Circulation, 2008; 117: 2608-2616.
4. Bax JJ, Gorcsan J 3rd. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: Results of the prospect (predictors of response to cardiac resynchronization therapy) study in perspective. J Am Coll Cardiol, 2009; 53: 1933-1943.
5. Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol, 2002; 39: 2026-2033.
6. Hürlimann D, Steffel J, Milosevic G et al. Cardiac resynchronization therapy: "Real world" experience from a swiss tertiary center. Cardiovasc Med (Basel), 2010; 13: 334-341.
7. Bertini M, Delgado V, Bax JJ, Van de Veire NR. Why, how and when do we need to optimize the setting of cardiac resynchronization therapy? Europace, 2009; 11 (suppl. 5): v46-v57.
8. O'Donnell D, Nadurata V, Hamer A, Kertes P, Mohamed U. Long-term variations in optimal programming of cardiac resynchronization therapy devices. Pacing Clin Electrophysiol, 2005; 28 (suppl. 1): S24-S26.
9. Porciani MC, Dondina C, Macioce R et al. Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail, 2006; 12: 715-719.
10. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm, 2004; 1: 562-567.
11. Morales MA, Startari U, Panchetti L, Rossi A, Piacenti M. Atrioventricular delay optimization by Doppler-derived left ventricular dp/dt improves 6-month outcome of resynchronized patients. Pacing Clin Electrophysiol, 2006; 29: 564-568.
12. Hardt SE, Yazdi SH, Bauer A et al. Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy. Int J Cardiol, 2007; 115: 318-325.
13. Vidal B, Tamborero D, Mont L et al. Electrocardiographic optimization of interventricular delay in cardiac resynchronization therapy: A simple method to optimize the device. J Cardiovasc Electrophysiol, 2007; 18: 1252-1257.
14. Kedia N, Ng K, Apperson-Hansen C et al. Usefulness of atrioventricular delay optimization using Doppler assessment of mitral infow in patients undergoing cardiac resynchronization therapy. Am J Cardiol, 2006; 98: 780-785.
15. Ellenbogen KA, Gold MR, Meyer TE et al. Primary results from the smartdelay determined av optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation, 2010; 122: 2660-2668.
16. Auricchio A, Stellbrink C, Block M et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The pacing therapies for congestive heart failure study group. The guidant congestive heart failure research group. Circulation, 1999; 99: 2993-3001.
17. Brenyo A, Kutyifa V, Moss AJ et al. Atrioventricular delay programming and the beneft of cardiac resynchronization therapy in MADIT-CRT. Heart Rhythm, 2013; 10: 1136-1143.
18. Delnoy P P, Ritter P, Naegele H et al. Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: A post hoc analysis of the clinical evaluation on advanced resynchronization (CLEAR) pilot study. Europace, 2013; 15: 1174-1181.
19. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005; 352: 1539-1549.
20. Abraham W T, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med, 2002; 346: 1845-1853.
21. Meluzin J, Novak M, Mullerova J et al. A fast and simple echocardiographic method of determination of the optimal atrioventricular delay in patients after biventricular stimulation. Pacing Clin Electrophysiol, 2004; 27: 58-64.
22. van Gelder BM, Bracke FA, Meijer A, Pijls NH. The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. J Am Coll Cardiol, 2005; 46: 2305-2310.
23. Pires LA, Abraham W T, Young JB, Johnson KM; MIRACLE Investigators M-I. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the multicenter InSync randomized clinical evaluation (MIRACLE) and multicenter InSync ICD randomized clinical evaluation (MIRACLE-ICD) trials. Am Heart J, 2006; 151: 837-843.
24. Vatasescu R, Berruezo A, Mont L et al. Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: Insights from electro-anatomical mapping. Europace, 2009; 11: 1675-1682.
25. Butter C, Auricchio A, Stellbrink C et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation, 2001; 104: 3026-3029.
26. Sogaard P, Egeblad H, Pedersen AK et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: Evaluation by tissue Doppler imaging. Circulation, 2002; 106: 2078-2084.
27. Vanderheyden M, De Backer T, Rivero-Ayerza M et al. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy. Heart Rhythm, 2005; 2: 1066-1072.
28. Leon AR, Abraham WT, Brozena S et al.; InSync IIICSI. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol, 2005; 46: 2298-2304.
29. Rao RK, Kumar UN, Schafer J, Viloria E, De Lurgio D, Foster E. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation, 2007; 115: 2136-2144.
30. Boriani G, Muller C P, Seidl KH et al. Resynchronization for the HemodYnamic Treatment for Heart Failure Management III. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The resynchronization for the hemodynamic treatment for heart failure management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J, 2006; 151: 1050-1058.
31. Whinnett ZI, Davies JE, Willson K et al. Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: Analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay. Heart, 2006; 92: 1628-1634.
32. Corley SD, Epstein AE, DiMarco JP et al.; Investigators A. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation, 2004; 109: 1509-1513.
33. Gasparini M, Auricchio A, Metra M et al. Multicentre Longitudinal Observational Study G. Long-term survival in patients undergoing cardiac resynchronization therapy: The importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J, 2008; 29: 1644-1652.